30 Participants NeededMy employer runs this trial

Systane PRO for Dry Eye Syndrome

(SYSTANEvBLINK Trial)

RO
Overseen ByRylee Owen
Age: 18+
Sex: Any
Trial Phase: Phase 4
Sponsor: Gordon Schanzlin New Vision
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this investigational study is to determine if Systane PRO Preservative Free is non-inferior to BLINK TRIPLE CARE in the clinically significant improvement of signs and symptoms of dry eye in patients over 4 weeks.

Who Is on the Research Team?

DI

David I Geffen, Doctor Of Optometry

Principal Investigator

Gordon Schanzlin New Vision Institute

Are You a Good Fit for This Trial?

This trial is for people diagnosed with dry eye syndrome. Participants must meet certain health criteria, but specific inclusion and exclusion details are not provided.

Inclusion Criteria

OSDI ≥ 13 to ≤ 32 at screening
Objective evidence: NITBUT ≤ 10 seconds in the study eye(s) at screening
Women of childbearing potential must agree to use an acceptable method of contraception for the study duration and have a negative pregnancy test at screening
See 5 more

Exclusion Criteria

I do not have diseases or medications that affect my tear production or eye surface health.
I have an active eye infection or inflammation not caused by dry eye disease.
Pregnancy or breastfeeding
See 10 more

What Are the Treatments Tested in This Trial?

Trial Overview

The study compares two preservative-free eye drops—Systane PRO and Blink Triple Care—to see if Systane PRO works as well as Blink in improving dry eye symptoms over 4 weeks.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Systane PRO PFExperimental Treatment1 Intervention
Group II: BLINK TRIPLE CARE PFActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Gordon Schanzlin New Vision

Lead Sponsor

Trials
2
Recruited
50+